Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW
4,870.00
+85.00 (1.78%)
Apr 1, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 130.44B | 120.57B | 112.49B | 110.05B | 103.39B | | | |
| | | 8.18% | 7.19% | 2.22% | 6.44% | -1.97% | | | |
| | | 4.10B | 2.99B | 4.02B | 3.96B | 2.43B | | | |
| | | 36.97% | -25.53% | 1.47% | 62.98% | 58.42% | | | |
| | | 837.86M | 3.03B | 3.26B | 16.47B | 5.32B | | | |
Non-Pharmaceutical Growth | | | -72.33% | -7.09% | -80.21% | 209.63% | - | | | |
Intersectoral Coordination | | | - | -7.78M | -17.48M | -80.16M | -17.62M | | | |
| | | 135.37B | 126.58B | 119.75B | 130.39B | 111.12B | | | |
| | | 6.94% | 5.71% | -8.17% | 17.34% | 3.20% | | | |
Source: S&P Global Market Intelligence.
